Metformin

The provided articles do not mention "Metformin" as an organization or entity. Instead, they focus on the topic of Long Covid and the recent decision by German statutory health insurance funds (Krankenkassen) to cover the costs of certain medications for Long Covid patients. These medications, including the antidepressant Agomelatin, are being used 'off-label' to alleviate symptoms like fatigue, a common complaint among Long Covid sufferers. While these drugs are not a cure, they aim to improve the quality of life for those experiencing prolonged symptoms after a viral infection, such as COVID-19 or influenza. The news is significant because it provides easier access to treatment for Long Covid patients who previously had to pay for these medications themselves.